Skip to search formSkip to main contentSkip to account menu

WR-6026

Known as: WR-006026, WR6026, WR 6026 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
In order to verify the viability of platelet concentrate during its preservation period when added with two trypanosomicidal… 
1999
1999
WR 6026 is an 8-aminoquinoline with activity against Pneumocystis carinii in vitro and in an animal model of P. carinii pneumonia… 
1998
1998
Abstract : During the reporting period, Two Week Oral Toxicity Studies of WR2425 11 and WR2694 10 in Rats, In Vitro Mutagenicity… 
1995
1995
Abstract : This study evaluated the developmental toxicity of WR6026 Dihydrochloride in time-mated New Zealand White (Pasteurella… 
1992
1992
Experimental 8-aminoquinolines from Walter Reed Army Institute for Research are effective for prophylaxis or therapy of… 
1990
1990
The kinetics of the oxidation of hemoglobin (Hb) and myoglobin (Mb) by sodium nitrite, 8‐[(4‐amino‐1‐methylbutyl)amino]‐6‐methoxy… 
1988
1988
Abstract : WR 6026 is a promising agent for the treatment of visceral leishmaniasis based on experiments in both an animal model… 
1983
1983
Abstract : The purpose of these experiments was to establish the effects of intravenous infusions of WR-228,258 on the rhythm…